Variant report
Variant | esv3438162 |
---|---|
Chromosome Location | chr8:52611199-52615497 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556452679 | chr8:52611226-52611227 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs114083472 | chr8:52611234-52611235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138961005 | chr8:52611242-52611243 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs10091454 | chr8:52611254-52611255 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs72642948 | chr8:52611281-52611282 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs545614509 | chr8:52611373-52611374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10106091 | chr8:52611394-52611395 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs182109168 | chr8:52611459-52611460 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs539011240 | chr8:52611497-52611498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185907128 | chr8:52611525-52611526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569165674 | chr8:52611561-52611562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs114271929 | chr8:52611590-52611591 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs555760700 | chr8:52611614-52611615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548148455 | chr8:52611627-52611628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566553116 | chr8:52611628-52611629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576280790 | chr8:52611630-52611631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374359150 | chr8:52611652-52611653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534293457 | chr8:52611693-52611694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558833853 | chr8:52611715-52611716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs13270001 | chr8:52611722-52611723 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs191552502 | chr8:52611762-52611763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs115828499 | chr8:52611774-52611775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs574757916 | chr8:52611793-52611794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542173108 | chr8:52611846-52611847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553787175 | chr8:52611856-52611857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs35484637 | chr8:52611892-52611893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571987071 | chr8:52612092-52612093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142879615 | chr8:52612102-52612103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs147047056 | chr8:52612137-52612138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs34166264 | chr8:52612144-52612145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs111881289 | chr8:52612157-52612158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs182872304 | chr8:52612165-52612166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188736071 | chr8:52612170-52612171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562762345 | chr8:52612171-52612172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374559434 | chr8:52612181-52612182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs548514073 | chr8:52612187-52612188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs560115038 | chr8:52612203-52612204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs527641750 | chr8:52612248-52612249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148086178 | chr8:52612257-52612258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs141816521 | chr8:52612259-52612260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570823422 | chr8:52612264-52612265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113387826 | chr8:52612295-52612296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs56152651 | chr8:52612301-52612302 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs549980170 | chr8:52612304-52612305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568296505 | chr8:52612318-52612319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs72642949 | chr8:52612366-52612367 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs78779687 | chr8:52612392-52612393 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
48 | rs572306373 | chr8:52612399-52612400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs539022633 | chr8:52612454-52612455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs191941944 | chr8:52612467-52612468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22522925 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:52606000-52614200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr8:52609400-52614400 | Weak transcription | Right Atrium | heart |
3 | chr8:52610000-52611600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr8:52611600-52614000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr8:52614000-52614600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr8:52614200-52614400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr8:52614400-52614800 | Enhancers | Right Atrium | heart |
8 | chr8:52614400-52615000 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr8:52614600-52614800 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr8:52614800-52615000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr8:52614800-52615200 | Enhancers | Psoas Muscle | Psoas |
12 | chr8:52614800-52615200 | Active TSS | Right Atrium | heart |
13 | chr8:52614800-52615400 | Enhancers | Adipose Nuclei | Adipose |
14 | chr8:52615000-52615200 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr8:52615000-52615400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr8:52615200-52615400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
17 | chr8:52615400-52615600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |